NFKB1 and colorectal cancer: GPR109A expression was dysregulated in colorectal cancers because of DNA methylation, and the receptor could be activated by butyrate in CRC cell lines, which eliminates Nuclear factor kappa-B (NF-κB) activation and induces apoptosis [45].